Our analysis of an existing dataset (GSE19429) revealed that PTTG3P levels in the CD34+ subset of MDS‐RAEB (36.85 vs 47.11, P = 0.0003) were lower than those in normal counterparts (Figure S7D‐E). This evidence concerns the gene PTTG3P and myelodysplastic syndrome with excess blasts.